Inside Precision Medicine June 17, 2024
IPM staff

With better methods needed for matching patients with depression with appropriate treatments, researchers at Stanford University, reporting today in Nature Medicine, say they have identified six biological subtypes (biotypes) of depression. The team also identified existing treatments that could be more likely, or less likely, to be effective against three of those biotypes.

According to statistics from the National Institute of Mental Health’s 2021 National Survey on Drug Use and Health, roughly 21 million people (8.3% of the population) in the United States suffer from major depression. The rates are significantly higher for women (10.3%) than for males (6.2%). Major depression is defined as a period of at least two weeks when a person experienced a depressed mood or loss...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Mental Health, Provider, Radiology, Survey / Study, Technology, Trends
988 Mental Health Hotline Failed to Boost Service Offerings
Suicide hotline has not led to increased mental health service access: Study
Private Equity Investors Are Still Laser-Focused on Behavioral Health Care
Private Equity in Behavioral Health: Compliance Champions or Cost-Cutting Villains?
Private equity-backed company acquires New York behavioral provider

Share This Article